Negative modulation of nitric oxide production by neurotensin as a putative mechanism of the diuretic action of SR 48692 in rats

British Journal of Pharmacology

Volumn 120, Issue 7, 1997, Pages 1312-1318

  Croci, Tiziano ^a   Landi, Marco ^a   Gully, Danielle ^b   Maffrand, Jean Pierre ^b   Le Fur, Gérard ^c   Manara, Luciano ^a  

^a Research Center Sanofi Midy   (Italy)

^b SANOFI   (France)

^c NONE   (France)

Author keywords

Arginine vasopressin; Diuresis; Furosemide; Isosorbide dinitrate; N( ) nitro L arginine methyl ester (L NAME); Neurotensin; Nitric oxide; SR 48692

Indexed keywords

2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; ARGININE; CHLORIDE ION; DIURETIC AGENT; FUROSEMIDE; ISOSORBIDE DINITRATE; N(G) NITROARGININE METHYL ESTER; NEUROTENSIN; NITRATE; NITRIC OXIDE; NITRITE; POTASSIUM ION; SODIUM ION;

ANIMAL EXPERIMENT; ARTICLE; CHLORIDE URINE LEVEL; CONTROLLED STUDY; DIET RESTRICTION; DIURESIS; DIURETIC ACTIVITY; DOSE RESPONSE; FOOD INTAKE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; KALIURESIS; KIDNEY FUNCTION; MALE; MODULATION; NATRIURESIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE; URINE LEVEL; URINE OSMOLALITY; URINE VOLUME;

ANIMALS; ARGININE; CARDIOVASCULAR SYSTEM; DEXAMETHASONE; DIURETICS; ELECTROLYTES; FOOD; FUROSEMIDE; MALE; NEUROTENSIN; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PYRAZOLES; QUINOLINES; RATS; RECEPTORS, NEUROTENSIN; WATER;

EID: 0030890835     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701016     Document Type: Article

References (35)

1. AZZI, M., GULLY, D., HEAULME, M., BÉROD, A., PÉLAPRAT, D., KITABGI, P., BOIGEGRAIN, R., MAFFRAND, J.P., LE FUR, G. & ROSTÈNE, W. (1994). Neurotensin receptor interaction with dopaminergic systems in the guinea-pig hrain shown by neurotensin receptor antagonists. Eur. J. Pharmacol., 255, 167 - 174.
2. BACHMANN, S. & MUNDLL, P. (1994). Nitric oxide in the kidney: synthesis, localization, and function. Am. J. Kidney Dis., 24, 112 - 129.
3. BAYLIS, C., HARTON, P. & ENGELS, K. (1990). Endothelial derived relaxing factor controls renal hemodynamics in the normal rat kidney. J. Am. Soc. Nephrol., 1, 875 - 881.
4. BLACKBURN, A.M.. FLETCHER, D.R., BLOOM, S.R., CHRISTOFIDES, N.D., LONG, R.G., FITZPATRICK, M.L. & BARON, J.H. (1980). Effect of neurotensin on gastric function in man. Lancet, i, 987 - 989.
5. BLOOM, S.R., PEART, W.S. & UNWIN, R.J. (1983). Neurotensin and antinatriuresis in the conscious rabbit. Br. J. Pharmacol., 79, 15 - 18.
6. 3H]dopamine release in rat striatal slices and mesencephalic culture. Eur. J. Pharmacol., 253, 289 - 291.
7. BRUN, P., STEINBERG, R., LE FUR, G. & SOUBRIÉ, P. (1995). Blockade of neurotensin receptor by SR 48692 potentiates the facilitatory effect of haloperidol on the evoked in vivo dopamine release in the rat nucleus accumbens. J. Neurochem., 64, 2073 - 2079.
8. CROCI, T., GIUDICE, A., MANARA, L., GULLY, D. & LE FUR, G. (1995a). Promotion by SR 48692 of gastric emptying and defecation in rats suggesting a role of endogenous neurotensin. Br. J. Pharmacol., 115, 383 - 384.
9. 1A receptors. Br. J. Pharmacol., 114, 203 - 209.
10. CROCI, T., LANDI, M., GULLY, D., MAFFRAND, J.P., LE FUR, G. & MANARA, L. (1996). Negative modulation of nitric oxide production by neurotensin as a putative mechanism of the diuretic action of its specific antagonist SR 48692, in rats. FASEB J., 10, A439.
11. DE NICOLA, L., BLANTZ, R.C. & GABBAI, F.B. (1992). Nitric oxide and angiotensin II. Glomerular and tubular interaction in the rat. J. Clin. Invest. 89, 1248 - 1256.
12. DUBUC, I., COSTENTIN, J., TERRANOVA, J.P. , BARNOUIN, M.C., SOUBRIÉ, P., LE FUR, G., ROSTÉNE, W. & KITABGI, P. (1994). The non-peptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes. Br. J. Pharmacol. 112, 352 - 354.
13. FERRIS, C.F. (1989). Neurotensin. In Handbook of Physiology: The Gastrointestinal System Vol. 2, ed. Makhlouf G.M., pp. 559 - 586, NY: Oxford University press.
14. GREGER, R. (1985). Ion transport mechanisms in thick ascending limb of Henle's loop of mammalian nephron. Physiol. Rev., 65, 760 - 797.
15. GULLY, D., CANTON, M., BOIGEGRAIN, R., JEANJEAN F., MOLINARD, J.C., PONCELET, M., GUEUDET, C., HEAULME, M., LEYRIS, R., BROUARD, A., PELAPRAT, D., LABBÉ-JULLIÉ, C., MAZELLA, J., SOUBRIÉ, P., MAFFRAND, J.P., ROSTÉNE, W., KITABGI, P. & LE FUR, G. (1993). Biochemical and pharmacological profile of a potent and selective non-peptide antagonist of the neurotensin receptor. Proc. Natl. Acad. Sci. U.S.A., 90, 65 - 69.
16. KJVLIGHN, S.D. & JANDHYALA, B.S. (1990). Antidiuretic effects of neurotensin in chloralose anaesthetized dogs. Clin. Exp. Pharmacol. Physiol., 17, 401 - 412.
17. KRAMER, C.Y. (1956). Extension of multiple range test to groups with unequal numbers of replications. Biometrics, 12, 307 - 310.
18. LEANDER, J.D., HART, J.C. & ZERBE, R.L. (1987). Kappa agonist-induced diuresis: evidence for stereoselectivity. strain differences, independence of hydration variables and a result of decreased plasma vasopressin levels. J. Pharmacol. Exp. Ther., 242, 33 - 39.
19. LESNIEWSKA, B., NUSSDORFER, G.G., NOWAK, M. & MALENDOWICZ, L.K. (1992). Comparison of the effects of neurotensin and vasopressin on the adrenal cortex of dexamelhasone-suppressed rats. Neuropeptides., 23, 9 - 13.
20. MAFFRAND, J.P., GULLY, D., BOIGEGRAIN, R., SOUBRIÉ, P., KITABGI, P., ROSTENE, W. & LE FUR, G. (1993). Neurotensin receptor agonists and antagonists. Drugs of the Future. 18, 1137 - 1141.
21. MALENDOWICZ, L.K. & NUSSDORFER, G.G. (1994). Modulatory action of neurotensin on the pituitary-adrenocortical function in rats: evidence for an acute dose-dependent biphasic effect. Life Sci., 55, 201 - 205.
22. MASHFORD, M.L., NILSON, G., ROKAEUS, A. & ROSELL, S (1978). The effect of food ingestion on circulating neurotensin-like immunoreactivity (NTLI) in the human. Acta Physiol. Scand., 104, 244 - 246.
23. MASILAMANI, S., CASTRO, L. & BAYLIS, C. (1994). Pregnant rats are refractory to the natriuretic actions of atrial natriuretic peptide. Am. J. Physiol., 267, R1611 - R1616.
24. MAZZOCCHI, G., MALENDOWICZ, L.K., ROCCO, S., MUSAJO, F & NUSSDORFER, G.G. (1993). Arginine-vasopressin release mediates the aldosterone secretagogue effect of neurotensin in rats. Neuropeptdes, 24, 105 - 108.
25. MONCADA, S. & HIGGS, E.A. (1995). Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J., 9, 1319 - 1330.
26. NISATO, D., GUIRAUDOU, P., BARTHELEMY, G., GULLY, D. & LE FUR, G. (1994). SR 48692, a non-peptide neurotensin antagonist blocks the cardiovascular effects elicited by neurotensin in guinea-pigs. Life Sci., 54, PL 95 - 100.
27. NUSSDORFER, G.G., MALENDOWICZ, L.K., MENEGHELLI, V. & MAZZOCCHI, G. (1992). Neurotensin enhances plasma adreno-corticotropin concentration by stimulating corticotropin-releasing hormone secretion. Life Sci., 50, 639 - 643.
28. QUIRION, R., GAUDREAU, P., ST-PIERRE, S. & RIOUX F. (1982). Localization of neurotensin binding sites in rat kidney. Peptides. 3, 765 - 769.
29. RADERMACHER, J., KLANKE B., SCHUREK, H.J., STOLTE, H.F. & FRÖHLICH, J.C (1992). Importance of EDRF/NO for glomerular and tubular function: Studies in the isolated perfused rat kidney. Kidney Int., 41, 1549 - 1559.
30. 11]neurotensin on mesolimbic dopaminergic function. Neuropeptides, 28, 43 - 50.
31. UNWIN, R.J., CALAM, J., PEART, W.S., HANSON, C., LEE, Y.C. & BLOOM, S.R. (1987). Renal function during bovine neurotensin infusion in man. Regul. Peptides, 18, 29 - 35.
32. VITA, N., LAURENT, P., LEPORT, S., CHALON, P., DUMONT, X., KAGHAD, M., GULLY, D., LE FUR, G. & CAPUT, D. (1993). Cloning and expression of a complementary DNA encoding high affinity human neurotensin receptor. Febs Lett., 317, 139 - 142.
33. WATANABE, F. (1988). Effects of halogen ion on chloride electrode. J. Medic. Tech. 32, 1667 - 1668.
34. WIEMER, G., FINK, E., LINZ, W., HROPOT, M., SCHOLKENS, B.A. & WOHLFART, P. (1994). Furosemide enhances the release of endothelial kinins, nitric oxide and prostacyclin. J. Pharmacol. Exp. Ther. 271, 1611 - 1615.
35. WORTH, H.G.J. (1988). Measurement of sodium and potassium in clinical chemistry: A review. Analyst, 113, 373 - 384.